冠状瘤的基因组概况和临床表现
Hela Koka1, Weiyin Zhou1,2, Mary L McMaster1
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Acta neuropathologica communications
|August 12, 2024
概括
这项研究揭示了基于瘤位置的冠状瘤显著的基因组差异,影响治疗结果. 特定的遗传缺失,如14q和18p,与持久性心脏瘤有关,突出显示了基因组异质性.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 基因组学就是基因组学.
背景情况:
- 胆瘤是一种罕见的骨癌,具有多样化的临床结果.
- 了解其遗传基础对于改善患者预后至关重要.
- 之前的研究已经确定了一些遗传变异,但对患者队伍进行全面的基因组分析是有限的.
研究的目的:
- 为了研究零星胆瘤的基因组景观.
- 确定与临床进展相关的潜在遗传驱动因素和生物标志物.
- 探索瘤部位和基因组改变之间的关系.
主要方法:
- 从美国和加拿大招募了184名零星性胆瘤患者.
- 收集的临床和治疗数据.
- 在一组患者 (N=70) 上进行了欧米克分析,包括针对性面板测序和SNP阵列基因型化.
主要成果:
- 确定PIK3CA (12%) 作为一个复发的体质驱动突变,其次是PBRM1和SETD2.
- 在16.3%的患者中检测到6q27区域 (含有TBXT) 的放大.
- 与圣骨性瘤相比,悬崖性瘤显示出较少的驱动突变和6q27放大.
- 14q (OR=13.73) 和18p (OR=13.68) 的体质缺失与持续性心脏瘤有显著的关联.
结论:
- 冠状瘤表现出显著的基因组异质性,受瘤位置的影响.
- 特定的遗传变化,如14q和18p删除,是持续性疾病的预测.
- 这些发现提供了对瘤病原体和潜在治疗点的见解.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.9K
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:27Growth of Cartilage and Bone Tissue
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:23Degenerative Disc Disease ll: Pathophysiology
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...